Trident Lifeline Ltd. (TLL): Trident Lifeline Share Price Near 52-Week High as TLL Trades at Rs 322
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Trident Lifeline Share Price is trading at Rs 322, up Rs 6.95 or 2.21% from the previous close, and remains close to its 52-week high after touching Rs 330 in the morning trade. Trident Lifeline Ltd. (TLL) carries a market capitalisation of Rs 376.71 Cr, which places the move in a clear valuation and market-size context for Trident Lifeline Share Price Today. The latest Univest figures confirm the stock event, but they do not establish a company-specific catalyst.
The stock opened at Rs 322.55 and moved between Rs 316.2 and Rs 330 during the morning session, with turnover at Rs 1.26 Cr. For readers tracking Trident Lifeline Stock News, the combination of a near one-year high, a positive day change and a compact price range is what makes the update relevant. Univest is following the stock because the move keeps Trident Lifeline Share Price near its yearly high while the broader numbers continue to frame the discussion around fundamentals and sector comparison.
Trident Lifeline Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 322 |
| Previous Close | Rs 315.05 |
| Today's Move | +Rs 6.95 (+2.21%) |
| Open | Rs 322.55 |
| High | Rs 330 |
| Low | Rs 316.2 |
| Turnover | Rs 1.26 crore |
| Market Capitalisation | Rs 376.71 crore |
Trident Lifeline Ltd. (TLL) traded at Rs 322 versus the previous close of Rs 315.05, a rise of 2.21%. The stock opened at Rs 322.55, reached a high of Rs 330 and touched a low of Rs 316.2.
Trident Lifeline Share Price Today shows a clear upward move versus the previous close. The stock traded at Rs 322 against Rs 315.05 yesterday, adding Rs 6.95 or 2.21%. It opened at Rs 322.55, moved up to Rs 330 and was seen as low as Rs 316.2 in the session. Turnover stood at Rs 1.26 Cr, which gives a factual view of the trading value behind the move without adding anything beyond the price record itself.
Because the stock is trading near its 52-week high, this price action is drawing attention in Trident Lifeline Share Price Live and Trident Lifeline Share Price Update searches. The stock is also comfortably above the previous close by a small absolute amount, and the latest move keeps Trident Lifeline Stock News focused on the relation between the current quote and the yearly high rather than on any unsupported explanation.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 376.71 crore |
| P/E Ratio | 19.78x |
| P/B Ratio | 3.82x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.92 |
| Book Value Per Share | Rs 82.4 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 19.78x, P/B 3.82x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.
Trident Lifeline Ltd. has a market capitalisation of Rs 376.71 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 19.78x, P/B at 3.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.32x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 19.78x |
| Benchmark Median P/E | 28.32x |
| Benchmark Average P/E | 40.51x |
| Benchmark P/E Range | 0x to 683.5x |
| Company P/B Ratio | 3.82x |
| Benchmark Median P/B | 3x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 376.71 crore |
| Benchmark Median Market Cap | Rs 726 crore |
Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 19.78x, which is below the benchmark median of 28.32x, a difference of -30.16%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.69%, a difference of +60.65%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.32%, a difference of +43.92%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Astonea Labs Ltd. | ASTONEALAB | 372.61 | 82.52 | 6.52 | 11.95 | 10.51 |
| iStreet Network Ltd. | ISTRNETWK | 342.27 | 84.24 | 7.01 | 0 | 154.44 |
| Jenburkt Pharmaceuticals Ltd. | JENBURPH | 431.62 | 13.15 | 2.13 | 18.84 | 25.34 |
| SMS Lifesciences India Ltd. | HALEOSLABS | 447.49 | 28.32 | 2.08 | 10.03 | 12.6 |
| Medicamen Biotech Ltd. | MEDICAMEQ | 447.91 | 41.36 | 1.66 | 3.23 | 5.77 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 19.78x compared with the displayed peer median of 41.36x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 10.03% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 12.6%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 376.71 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Trident Lifeline
- Trident Lifeline Share Price is Rs 322, up 2.21% from the previous close of Rs 315.05.
- The stock touched Rs 330 during the session and stayed near its 52-week high.
- Market capitalisation is Rs 376.71 Cr, which gives scale to the move.
- P/E is 19.78 and P/B is 3.82, both useful in Trident Lifeline Fundamental Analysis.
- ROE of 18.78% and ROCE of 19.17% add context for Trident Lifeline Stock News today.
About Trident Lifeline
Trident Lifeline Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. That classification is the clearest company-level profile available for Trident Lifeline Share Price readers, and it helps position the stock within the broader Indian pharmaceutical universe. For Univest readers following Trident Lifeline Company News, the industry label and market-cap data are the main anchors provided here.
Frequently Asked Questions
Why is Trident Lifeline Share Price in focus today?
Ans. Trident Lifeline Share Price is in focus because it is trading at Rs 322, up 2.21% from the previous close, and remains near its 52-week high after touching Rs 330 during the session.
What is Trident Lifeline Share Price Today?
Ans. Trident Lifeline Share Price Today is Rs 322. The stock is up Rs 6.95 from the previous close of Rs 315.05, and the day’s range has stayed between Rs 316.2 and Rs 330.
How close is Trident Lifeline to its 52-week high?
Ans. Trident Lifeline is trading near its 52-week high because the session high of Rs 330 keeps the stock close to that yearly peak. The current price of Rs 322 remains in that zone.
What is Trident Lifeline market cap?
Ans. Trident Lifeline has a market capitalisation of Rs 376.71 Cr. That figure helps place Trident Lifeline Share Price in context and is one reason the stock stays on market screens today.
What does Trident Lifeline P/E ratio show?
Ans. Trident Lifeline’s P/E ratio is 19.78. In the same industry set, that sits below the median of 28.32 and well below the average of 40.51, offering a useful valuation comparison.
What do ROE and ROCE mean for Trident Lifeline?
Ans. Trident Lifeline reports ROE of 18.78% and ROCE of 19.17%. Those numbers indicate the company’s return metrics are above the industry medians shown in the same-industry benchmark. The relevant peer median ROE is 11.69%.
What are Trident Lifeline EPS and book value?
Ans. EPS is Rs 15.92 and book value is Rs 82.4 per share. EPS reflects earnings attributable to each share, while book value shows accounting net worth per share at the latest reference point.
What is the sector and industry for Trident Lifeline?
Ans. Trident Lifeline operates in Healthcare and the Pharmaceuticals & Drugs industry. This sector context matters for Trident Lifeline Stock News because the peer set and benchmark ratios are drawn from the same industry group.
Track Trident Lifeline Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Trident Lifeline Share Price on Univest for live price updates, key ratios, market cap, 52-week levels, peer context and company insights. Univest also keeps Trident Lifeline Share News and Trident Lifeline Latest News organised for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
